Ebola survivors under the microscope: what happens after recovery?

NCT ID NCT04409405

First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 40 times

Summary

This completed study in the Democratic Republic of the Congo followed 787 people who survived Ebola and their close contacts. Researchers tracked their health over time, looking for lingering virus, immune responses, and other infections. The goal was to better understand the long-term consequences of Ebola and how to prevent further spread.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beni Hospital

    Beni, Democratic Republic of the Congo

  • Butembo Hospital

    Butembo, Democratic Republic of the Congo

  • Mambasa Hospital

    Mambasa, Democratic Republic of the Congo

  • Mangina Hospital

    Beni, Democratic Republic of the Congo

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could improve how we monitor and care for Ebola survivors and help prevent future outbreaks by understanding how the virus lingers or spreads.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove that any intervention works, and results may not apply to other regions or outbreaks.

Conditions

The condition(s) this trial relates to.

Ebola hemorrhagic fever

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.